SMITH STAN purchased 5.2% of their position (75K shares) of MAIA BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $100.2K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/2/2026ACC: 0001878313-26-000061
+75K
Net shares
Net buyer
$100.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
75K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+75K
Price / share
$1.34
Trade value
$100.20K
% of position
5.2%
6/1/2026
1.44M→1.52M
Total
Net shares
+75K
Net value
$100.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/1/2026 | P · Purchase | +75K | $1.34 | $100.20K | 5.2% | 1.44M | 1.52M |
| Total | +75K | $100.20K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned4.58K
Common Stock
IndirectShares owned4.58K
Common Stock
IndirectShares owned4.58K
Total
13.74K indirect13.74K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.58K | Indirect |
| Common Stock | 4.58K | Indirect |
| Common Stock | 4.58K | Indirect |
| Total | 13.74K | 13.74K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported